Supports members in addressing challenges in advanced therapy medicinal products through discussion teams and workstreams focused on development, analytics, commercialization, regulatory, and other areas.

Focuses on reducing product development lead times and exploiting new technologies through workstreams on speed to first-in-human, accelerating CMC development, and host cell proteins.